nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminoglutethimide—CYP19A1—osteoporosis	0.442	1	CbGaD
Aminoglutethimide—CYP11A1—Cholecalciferol—osteoporosis	0.162	0.349	CbGbCtD
Aminoglutethimide—CYP19A1—Raloxifene—osteoporosis	0.0979	0.21	CbGbCtD
Aminoglutethimide—CYP1A2—Estropipate—osteoporosis	0.0355	0.0762	CbGbCtD
Aminoglutethimide—CYP2C19—Cholecalciferol—osteoporosis	0.0198	0.0426	CbGbCtD
Aminoglutethimide—CYP3A4—Estropipate—osteoporosis	0.0186	0.0399	CbGbCtD
Aminoglutethimide—CYP3A4—Calcitriol—osteoporosis	0.0186	0.0399	CbGbCtD
Aminoglutethimide—CYP1A2—Conjugated Estrogens—osteoporosis	0.0168	0.0361	CbGbCtD
Aminoglutethimide—CYP2C19—Estradiol—osteoporosis	0.016	0.0343	CbGbCtD
Aminoglutethimide—CYP3A4—Ergocalciferol—osteoporosis	0.0149	0.0319	CbGbCtD
Aminoglutethimide—CYP1A2—Estradiol—osteoporosis	0.0147	0.0317	CbGbCtD
Aminoglutethimide—CYP3A4—Raloxifene—osteoporosis	0.0124	0.0266	CbGbCtD
Aminoglutethimide—CYP3A4—Ethinyl Estradiol—osteoporosis	0.012	0.0257	CbGbCtD
Aminoglutethimide—CYP3A4—Cholecalciferol—osteoporosis	0.00958	0.0206	CbGbCtD
Aminoglutethimide—CYP3A4—Conjugated Estrogens—osteoporosis	0.00879	0.0189	CbGbCtD
Aminoglutethimide—CYP3A4—Estradiol—osteoporosis	0.00772	0.0166	CbGbCtD
Aminoglutethimide—Hirsutism—Estropipate—osteoporosis	0.00228	0.0319	CcSEcCtD
Aminoglutethimide—Goitre—Estradiol—osteoporosis	0.00196	0.0275	CcSEcCtD
Aminoglutethimide—Hypothyroidism—Pamidronate—osteoporosis	0.00155	0.0217	CcSEcCtD
Aminoglutethimide—Hirsutism—Conjugated Estrogens—osteoporosis	0.00151	0.0211	CcSEcCtD
Aminoglutethimide—CYP11A1—Endogenous sterols—CYP27A1—osteoporosis	0.00126	0.0588	CbGpPWpGaD
Aminoglutethimide—Hirsutism—Estradiol—osteoporosis	0.00121	0.0169	CcSEcCtD
Aminoglutethimide—CYP11A1—Prostaglandin Synthesis and Regulation—ANXA2—osteoporosis	0.00116	0.0544	CbGpPWpGaD
Aminoglutethimide—Pancytopenia—Etidronic acid—osteoporosis	0.000914	0.0128	CcSEcCtD
Aminoglutethimide—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.000889	0.0416	CbGpPWpGaD
Aminoglutethimide—Anaemia—Ergocalciferol—osteoporosis	0.000834	0.0117	CcSEcCtD
Aminoglutethimide—CYP19A1—Endogenous sterols—CYP27A1—osteoporosis	0.000832	0.0389	CbGpPWpGaD
Aminoglutethimide—Agranulocytosis—Etidronic acid—osteoporosis	0.000801	0.0112	CcSEcCtD
Aminoglutethimide—Anorexia—Calcium Acetate—osteoporosis	0.000794	0.0111	CcSEcCtD
Aminoglutethimide—Hypotension—Calcium Acetate—osteoporosis	0.000779	0.0109	CcSEcCtD
Aminoglutethimide—Decreased appetite—Calcium Acetate—osteoporosis	0.000724	0.0101	CcSEcCtD
Aminoglutethimide—Anorexia—Ergocalciferol—osteoporosis	0.000702	0.00982	CcSEcCtD
Aminoglutethimide—Drowsiness—Calcitriol—osteoporosis	0.000697	0.00975	CcSEcCtD
Aminoglutethimide—CYP11A1—Endogenous sterols—CYP19A1—osteoporosis	0.00066	0.0309	CbGpPWpGaD
Aminoglutethimide—Decreased appetite—Ergocalciferol—osteoporosis	0.00064	0.00895	CcSEcCtD
Aminoglutethimide—Anaemia—Etidronic acid—osteoporosis	0.00062	0.00867	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Calcium Acetate—osteoporosis	0.000614	0.00859	CcSEcCtD
Aminoglutethimide—Leukopenia—Etidronic acid—osteoporosis	0.0006	0.00839	CcSEcCtD
Aminoglutethimide—Pruritus—Calcium Acetate—osteoporosis	0.00059	0.00825	CcSEcCtD
Aminoglutethimide—Neutropenia—Pamidronate—osteoporosis	0.000585	0.00818	CcSEcCtD
Aminoglutethimide—CYP11A1—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000583	0.0273	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000576	0.0269	CbGpPWpGaD
Aminoglutethimide—Dizziness—Calcium Acetate—osteoporosis	0.000551	0.00771	CcSEcCtD
Aminoglutethimide—Pancytopenia—Zoledronate—osteoporosis	0.000542	0.00759	CcSEcCtD
Aminoglutethimide—Neutropenia—Zoledronate—osteoporosis	0.000534	0.00747	CcSEcCtD
Aminoglutethimide—Vomiting—Calcium Acetate—osteoporosis	0.00053	0.00741	CcSEcCtD
Aminoglutethimide—Anaemia—Alendronate—osteoporosis	0.000528	0.00739	CcSEcCtD
Aminoglutethimide—Agranulocytosis—Pamidronate—osteoporosis	0.00052	0.00728	CcSEcCtD
Aminoglutethimide—Anaemia—Ibandronate—osteoporosis	0.000514	0.00719	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Etidronic acid—osteoporosis	0.000498	0.00697	CcSEcCtD
Aminoglutethimide—Nausea—Calcium Acetate—osteoporosis	0.000495	0.00692	CcSEcCtD
Aminoglutethimide—CYP11A1—Metabolism of steroid hormones and vitamin D—CYP19A1—osteoporosis	0.000494	0.0231	CbGpPWpGaD
Aminoglutethimide—Myalgia—Estropipate—osteoporosis	0.000494	0.00691	CcSEcCtD
Aminoglutethimide—Myalgia—Alendronate—osteoporosis	0.000486	0.0068	CcSEcCtD
Aminoglutethimide—Myalgia—Raloxifene—osteoporosis	0.000478	0.00669	CcSEcCtD
Aminoglutethimide—Agranulocytosis—Zoledronate—osteoporosis	0.000475	0.00665	CcSEcCtD
Aminoglutethimide—Myalgia—Ibandronate—osteoporosis	0.000473	0.00662	CcSEcCtD
Aminoglutethimide—CYP11A1—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000473	0.0221	CbGpPWpGaD
Aminoglutethimide—Myalgia—Calcitriol—osteoporosis	0.000464	0.00648	CcSEcCtD
Aminoglutethimide—Nausea—Ergocalciferol—osteoporosis	0.000437	0.00612	CcSEcCtD
Aminoglutethimide—Urticaria—Etidronic acid—osteoporosis	0.000435	0.00608	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Estropipate—osteoporosis	0.000431	0.00603	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Alendronate—osteoporosis	0.000425	0.00594	CcSEcCtD
Aminoglutethimide—Anaemia—Risedronate—osteoporosis	0.000424	0.00593	CcSEcCtD
Aminoglutethimide—Anorexia—Calcitriol—osteoporosis	0.000424	0.00592	CcSEcCtD
Aminoglutethimide—Somnolence—Estropipate—osteoporosis	0.000421	0.00589	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.000418	0.00584	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.000414	0.00578	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.000405	0.00566	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Etidronic acid—osteoporosis	0.000403	0.00564	CcSEcCtD
Aminoglutethimide—Anaemia—Pamidronate—osteoporosis	0.000403	0.00563	CcSEcCtD
Aminoglutethimide—CYP11A1—Endogenous sterols—POMC—osteoporosis	0.000397	0.0186	CbGpPWpGaD
Aminoglutethimide—Somnolence—Calcitriol—osteoporosis	0.000395	0.00553	CcSEcCtD
Aminoglutethimide—Decreased appetite—Ibandronate—osteoporosis	0.000395	0.00552	CcSEcCtD
Aminoglutethimide—Myalgia—Risedronate—osteoporosis	0.00039	0.00546	CcSEcCtD
Aminoglutethimide—Leukopenia—Pamidronate—osteoporosis	0.00039	0.00546	CcSEcCtD
Aminoglutethimide—Pruritus—Etidronic acid—osteoporosis	0.000387	0.00541	CcSEcCtD
Aminoglutethimide—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000386	0.0181	CbGpPWpGaD
Aminoglutethimide—Decreased appetite—Calcitriol—osteoporosis	0.000386	0.0054	CcSEcCtD
Aminoglutethimide—CYP19A1—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000381	0.0178	CbGpPWpGaD
Aminoglutethimide—Urticaria—Estropipate—osteoporosis	0.000376	0.00526	CcSEcCtD
Aminoglutethimide—Body temperature increased—Estropipate—osteoporosis	0.000374	0.00523	CcSEcCtD
Aminoglutethimide—Myalgia—Pamidronate—osteoporosis	0.000371	0.00519	CcSEcCtD
Aminoglutethimide—Urticaria—Alendronate—osteoporosis	0.00037	0.00518	CcSEcCtD
Aminoglutethimide—CYP19A1—Ovarian Infertility Genes—ESR2—osteoporosis	0.00037	0.0173	CbGpPWpGaD
Aminoglutethimide—Body temperature increased—Alendronate—osteoporosis	0.000369	0.00516	CcSEcCtD
Aminoglutethimide—Anaemia—Zoledronate—osteoporosis	0.000368	0.00515	CcSEcCtD
Aminoglutethimide—Body temperature increased—Raloxifene—osteoporosis	0.000362	0.00507	CcSEcCtD
Aminoglutethimide—Urticaria—Ibandronate—osteoporosis	0.000361	0.00504	CcSEcCtD
Aminoglutethimide—Body temperature increased—Ibandronate—osteoporosis	0.000359	0.00502	CcSEcCtD
Aminoglutethimide—Leukopenia—Zoledronate—osteoporosis	0.000356	0.00498	CcSEcCtD
Aminoglutethimide—Urticaria—Calcitriol—osteoporosis	0.000353	0.00494	CcSEcCtD
Aminoglutethimide—Body temperature increased—Calcitriol—osteoporosis	0.000351	0.00491	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Estropipate—osteoporosis	0.000349	0.00488	CcSEcCtD
Aminoglutethimide—Vomiting—Etidronic acid—osteoporosis	0.000348	0.00487	CcSEcCtD
Aminoglutethimide—Tachycardia—Pamidronate—osteoporosis	0.000347	0.00485	CcSEcCtD
Aminoglutethimide—Rash—Etidronic acid—osteoporosis	0.000345	0.00483	CcSEcCtD
Aminoglutethimide—Dermatitis—Etidronic acid—osteoporosis	0.000345	0.00482	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Alendronate—osteoporosis	0.000343	0.0048	CcSEcCtD
Aminoglutethimide—Headache—Etidronic acid—osteoporosis	0.000343	0.00479	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000341	0.00477	CcSEcCtD
Aminoglutethimide—Anorexia—Pamidronate—osteoporosis	0.000339	0.00474	CcSEcCtD
Aminoglutethimide—Myalgia—Zoledronate—osteoporosis	0.000339	0.00474	CcSEcCtD
Aminoglutethimide—Pruritus—Estropipate—osteoporosis	0.000335	0.00468	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Ibandronate—osteoporosis	0.000334	0.00468	CcSEcCtD
Aminoglutethimide—Hypotension—Pamidronate—osteoporosis	0.000332	0.00465	CcSEcCtD
Aminoglutethimide—Pruritus—Alendronate—osteoporosis	0.00033	0.00461	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Calcitriol—osteoporosis	0.000327	0.00458	CcSEcCtD
Aminoglutethimide—Myalgia—Conjugated Estrogens—osteoporosis	0.000326	0.00456	CcSEcCtD
Aminoglutethimide—Nausea—Etidronic acid—osteoporosis	0.000325	0.00455	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000324	0.00453	CcSEcCtD
Aminoglutethimide—Pruritus—Ibandronate—osteoporosis	0.000321	0.00449	CcSEcCtD
Aminoglutethimide—Tachycardia—Zoledronate—osteoporosis	0.000317	0.00443	CcSEcCtD
Aminoglutethimide—Somnolence—Pamidronate—osteoporosis	0.000316	0.00442	CcSEcCtD
Aminoglutethimide—Pruritus—Calcitriol—osteoporosis	0.000314	0.0044	CcSEcCtD
Aminoglutethimide—CYP19A1—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000313	0.0147	CbGpPWpGaD
Aminoglutethimide—Dizziness—Estropipate—osteoporosis	0.000313	0.00438	CcSEcCtD
Aminoglutethimide—Anorexia—Zoledronate—osteoporosis	0.00031	0.00433	CcSEcCtD
Aminoglutethimide—Decreased appetite—Pamidronate—osteoporosis	0.000309	0.00432	CcSEcCtD
Aminoglutethimide—Dizziness—Alendronate—osteoporosis	0.000308	0.00431	CcSEcCtD
Aminoglutethimide—CYP11A1—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000306	0.0143	CbGpPWpGaD
Aminoglutethimide—Tachycardia—Conjugated Estrogens—osteoporosis	0.000305	0.00427	CcSEcCtD
Aminoglutethimide—Urticaria—Ethinyl Estradiol—osteoporosis	0.000305	0.00426	CcSEcCtD
Aminoglutethimide—Hypotension—Zoledronate—osteoporosis	0.000304	0.00425	CcSEcCtD
Aminoglutethimide—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000303	0.00424	CcSEcCtD
Aminoglutethimide—Dizziness—Raloxifene—osteoporosis	0.000303	0.00424	CcSEcCtD
Aminoglutethimide—CYP11A1—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000302	0.0142	CbGpPWpGaD
Aminoglutethimide—Vomiting—Estropipate—osteoporosis	0.000301	0.00421	CcSEcCtD
Aminoglutethimide—Dizziness—Ibandronate—osteoporosis	0.0003	0.0042	CcSEcCtD
Aminoglutethimide—Rash—Estropipate—osteoporosis	0.000298	0.00417	CcSEcCtD
Aminoglutethimide—Dermatitis—Estropipate—osteoporosis	0.000298	0.00417	CcSEcCtD
Aminoglutethimide—Anorexia—Conjugated Estrogens—osteoporosis	0.000298	0.00417	CcSEcCtD
Aminoglutethimide—Urticaria—Risedronate—osteoporosis	0.000297	0.00416	CcSEcCtD
Aminoglutethimide—CYP11A1—Metabolism of steroid hormones and vitamin D—POMC—osteoporosis	0.000297	0.0139	CbGpPWpGaD
Aminoglutethimide—Headache—Estropipate—osteoporosis	0.000297	0.00415	CcSEcCtD
Aminoglutethimide—Vomiting—Alendronate—osteoporosis	0.000296	0.00415	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000296	0.00414	CcSEcCtD
Aminoglutethimide—Body temperature increased—Risedronate—osteoporosis	0.000296	0.00414	CcSEcCtD
Aminoglutethimide—Rash—Alendronate—osteoporosis	0.000294	0.00411	CcSEcCtD
Aminoglutethimide—Dermatitis—Alendronate—osteoporosis	0.000294	0.00411	CcSEcCtD
Aminoglutethimide—CYP19A1—Ovarian Infertility Genes—VDR—osteoporosis	0.000293	0.0137	CbGpPWpGaD
Aminoglutethimide—Hypotension—Conjugated Estrogens—osteoporosis	0.000292	0.00409	CcSEcCtD
Aminoglutethimide—Headache—Alendronate—osteoporosis	0.000292	0.00409	CcSEcCtD
Aminoglutethimide—Vomiting—Raloxifene—osteoporosis	0.000292	0.00408	CcSEcCtD
Aminoglutethimide—Rash—Raloxifene—osteoporosis	0.000289	0.00404	CcSEcCtD
Aminoglutethimide—Dermatitis—Raloxifene—osteoporosis	0.000289	0.00404	CcSEcCtD
Aminoglutethimide—Somnolence—Zoledronate—osteoporosis	0.000289	0.00404	CcSEcCtD
Aminoglutethimide—Vomiting—Ibandronate—osteoporosis	0.000289	0.00404	CcSEcCtD
Aminoglutethimide—Headache—Raloxifene—osteoporosis	0.000287	0.00402	CcSEcCtD
Aminoglutethimide—Rash—Ibandronate—osteoporosis	0.000286	0.004	CcSEcCtD
Aminoglutethimide—Dermatitis—Ibandronate—osteoporosis	0.000286	0.004	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000285	0.00399	CcSEcCtD
Aminoglutethimide—Headache—Ibandronate—osteoporosis	0.000284	0.00398	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000283	0.00395	CcSEcCtD
Aminoglutethimide—Vomiting—Calcitriol—osteoporosis	0.000283	0.00395	CcSEcCtD
Aminoglutethimide—Decreased appetite—Zoledronate—osteoporosis	0.000282	0.00395	CcSEcCtD
Aminoglutethimide—Nausea—Estropipate—osteoporosis	0.000281	0.00393	CcSEcCtD
Aminoglutethimide—Body temperature increased—Pamidronate—osteoporosis	0.000281	0.00393	CcSEcCtD
Aminoglutethimide—Rash—Calcitriol—osteoporosis	0.00028	0.00392	CcSEcCtD
Aminoglutethimide—Dermatitis—Calcitriol—osteoporosis	0.00028	0.00392	CcSEcCtD
Aminoglutethimide—Headache—Calcitriol—osteoporosis	0.000278	0.00389	CcSEcCtD
Aminoglutethimide—Somnolence—Conjugated Estrogens—osteoporosis	0.000278	0.00389	CcSEcCtD
Aminoglutethimide—Nausea—Alendronate—osteoporosis	0.000277	0.00387	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Risedronate—osteoporosis	0.000276	0.00386	CcSEcCtD
Aminoglutethimide—Nausea—Raloxifene—osteoporosis	0.000272	0.00381	CcSEcCtD
Aminoglutethimide—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000272	0.0038	CcSEcCtD
Aminoglutethimide—Pruritus—Ethinyl Estradiol—osteoporosis	0.000271	0.0038	CcSEcCtD
Aminoglutethimide—Nausea—Ibandronate—osteoporosis	0.00027	0.00377	CcSEcCtD
Aminoglutethimide—Pruritus—Risedronate—osteoporosis	0.000265	0.0037	CcSEcCtD
Aminoglutethimide—Nausea—Calcitriol—osteoporosis	0.000264	0.00369	CcSEcCtD
Aminoglutethimide—CYP19A1—Endogenous sterols—POMC—osteoporosis	0.000263	0.0123	CbGpPWpGaD
Aminoglutethimide—Hypersensitivity—Pamidronate—osteoporosis	0.000262	0.00366	CcSEcCtD
Aminoglutethimide—Myalgia—Estradiol—osteoporosis	0.000261	0.00365	CcSEcCtD
Aminoglutethimide—Urticaria—Zoledronate—osteoporosis	0.000258	0.00361	CcSEcCtD
Aminoglutethimide—Body temperature increased—Zoledronate—osteoporosis	0.000257	0.00359	CcSEcCtD
Aminoglutethimide—Dizziness—Ethinyl Estradiol—osteoporosis	0.000254	0.00355	CcSEcCtD
Aminoglutethimide—Pruritus—Pamidronate—osteoporosis	0.000252	0.00352	CcSEcCtD
Aminoglutethimide—CYP11A1—Biological oxidations—CYP27A1—osteoporosis	0.000251	0.0118	CbGpPWpGaD
Aminoglutethimide—Urticaria—Conjugated Estrogens—osteoporosis	0.000248	0.00348	CcSEcCtD
Aminoglutethimide—CYP11A1—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000248	0.0116	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metapathway biotransformation—CYP27A1—osteoporosis	0.000248	0.0116	CbGpPWpGaD
Aminoglutethimide—Dizziness—Risedronate—osteoporosis	0.000247	0.00346	CcSEcCtD
Aminoglutethimide—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000247	0.00346	CcSEcCtD
Aminoglutethimide—Tachycardia—Estradiol—osteoporosis	0.000244	0.00342	CcSEcCtD
Aminoglutethimide—Vomiting—Ethinyl Estradiol—osteoporosis	0.000244	0.00341	CcSEcCtD
Aminoglutethimide—Rash—Ethinyl Estradiol—osteoporosis	0.000242	0.00338	CcSEcCtD
Aminoglutethimide—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000242	0.00338	CcSEcCtD
Aminoglutethimide—Headache—Ethinyl Estradiol—osteoporosis	0.00024	0.00336	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Zoledronate—osteoporosis	0.000239	0.00335	CcSEcCtD
Aminoglutethimide—Vomiting—Risedronate—osteoporosis	0.000238	0.00333	CcSEcCtD
Aminoglutethimide—Rash—Risedronate—osteoporosis	0.000236	0.0033	CcSEcCtD
Aminoglutethimide—Dermatitis—Risedronate—osteoporosis	0.000236	0.0033	CcSEcCtD
Aminoglutethimide—Dizziness—Pamidronate—osteoporosis	0.000235	0.00329	CcSEcCtD
Aminoglutethimide—Headache—Risedronate—osteoporosis	0.000234	0.00328	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00023	0.00322	CcSEcCtD
Aminoglutethimide—Pruritus—Zoledronate—osteoporosis	0.00023	0.00321	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000228	0.00319	CcSEcCtD
Aminoglutethimide—Nausea—Ethinyl Estradiol—osteoporosis	0.000228	0.00319	CcSEcCtD
Aminoglutethimide—Vomiting—Pamidronate—osteoporosis	0.000226	0.00316	CcSEcCtD
Aminoglutethimide—Rash—Pamidronate—osteoporosis	0.000224	0.00314	CcSEcCtD
Aminoglutethimide—Dermatitis—Pamidronate—osteoporosis	0.000224	0.00313	CcSEcCtD
Aminoglutethimide—Headache—Pamidronate—osteoporosis	0.000223	0.00312	CcSEcCtD
Aminoglutethimide—Somnolence—Estradiol—osteoporosis	0.000223	0.00311	CcSEcCtD
Aminoglutethimide—Nausea—Risedronate—osteoporosis	0.000222	0.00311	CcSEcCtD
Aminoglutethimide—Pruritus—Conjugated Estrogens—osteoporosis	0.000221	0.0031	CcSEcCtD
Aminoglutethimide—Decreased appetite—Estradiol—osteoporosis	0.000218	0.00304	CcSEcCtD
Aminoglutethimide—Dizziness—Zoledronate—osteoporosis	0.000215	0.003	CcSEcCtD
Aminoglutethimide—Nausea—Pamidronate—osteoporosis	0.000211	0.00295	CcSEcCtD
Aminoglutethimide—Dizziness—Conjugated Estrogens—osteoporosis	0.000207	0.00289	CcSEcCtD
Aminoglutethimide—Vomiting—Zoledronate—osteoporosis	0.000207	0.00289	CcSEcCtD
Aminoglutethimide—Rash—Zoledronate—osteoporosis	0.000205	0.00286	CcSEcCtD
Aminoglutethimide—Dermatitis—Zoledronate—osteoporosis	0.000205	0.00286	CcSEcCtD
Aminoglutethimide—Headache—Zoledronate—osteoporosis	0.000203	0.00285	CcSEcCtD
Aminoglutethimide—Vomiting—Conjugated Estrogens—osteoporosis	0.000199	0.00278	CcSEcCtD
Aminoglutethimide—Urticaria—Estradiol—osteoporosis	0.000199	0.00278	CcSEcCtD
Aminoglutethimide—Body temperature increased—Estradiol—osteoporosis	0.000198	0.00277	CcSEcCtD
Aminoglutethimide—Rash—Conjugated Estrogens—osteoporosis	0.000197	0.00276	CcSEcCtD
Aminoglutethimide—Dermatitis—Conjugated Estrogens—osteoporosis	0.000197	0.00276	CcSEcCtD
Aminoglutethimide—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—osteoporosis	0.000197	0.00921	CbGpPWpGaD
Aminoglutethimide—Headache—Conjugated Estrogens—osteoporosis	0.000196	0.00274	CcSEcCtD
Aminoglutethimide—Nausea—Zoledronate—osteoporosis	0.000193	0.0027	CcSEcCtD
Aminoglutethimide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000188	0.00878	CbGpPWpGaD
Aminoglutethimide—Nausea—Conjugated Estrogens—osteoporosis	0.000186	0.0026	CcSEcCtD
Aminoglutethimide—CYP2C19—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000185	0.00866	CbGpPWpGaD
Aminoglutethimide—Hypersensitivity—Estradiol—osteoporosis	0.000184	0.00258	CcSEcCtD
Aminoglutethimide—CYP11A1—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000184	0.00862	CbGpPWpGaD
Aminoglutethimide—Pruritus—Estradiol—osteoporosis	0.000177	0.00248	CcSEcCtD
Aminoglutethimide—CYP1A2—Estrogen Receptor Pathway—ESR1—osteoporosis	0.000174	0.00816	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000168	0.00786	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Biological oxidations—CYP27A1—osteoporosis	0.000166	0.00779	CbGpPWpGaD
Aminoglutethimide—Dizziness—Estradiol—osteoporosis	0.000166	0.00232	CcSEcCtD
Aminoglutethimide—CYP19A1—Metapathway biotransformation—CYP27A1—osteoporosis	0.000164	0.00768	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000159	0.00745	CbGpPWpGaD
Aminoglutethimide—Vomiting—Estradiol—osteoporosis	0.000159	0.00223	CcSEcCtD
Aminoglutethimide—Rash—Estradiol—osteoporosis	0.000158	0.00221	CcSEcCtD
Aminoglutethimide—Dermatitis—Estradiol—osteoporosis	0.000158	0.00221	CcSEcCtD
Aminoglutethimide—Headache—Estradiol—osteoporosis	0.000157	0.00219	CcSEcCtD
Aminoglutethimide—CYP2C19—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000152	0.00712	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—RAP1A—osteoporosis	0.00015	0.00703	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000149	0.00699	CbGpPWpGaD
Aminoglutethimide—Nausea—Estradiol—osteoporosis	0.000149	0.00208	CcSEcCtD
Aminoglutethimide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000146	0.00684	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000144	0.00675	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.000142	0.00665	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Biological oxidations—CYP19A1—osteoporosis	0.000132	0.00618	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Corticotropin-releasing hormone—POMC—osteoporosis	0.000131	0.00612	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metapathway biotransformation—CYP19A1—osteoporosis	0.00013	0.00609	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000124	0.0058	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000122	0.00571	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000121	0.00565	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000118	0.00554	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000113	0.00528	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000111	0.00521	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000111	0.00521	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	0.000106	0.00497	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000106	0.00495	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000105	0.00494	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	9.89e-05	0.00463	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	9.85e-05	0.00461	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	9.72e-05	0.00455	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	9.65e-05	0.00451	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Tryptophan metabolism—CYP19A1—osteoporosis	9.5e-05	0.00444	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Arachidonic acid metabolism—GPX1—osteoporosis	9.28e-05	0.00434	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	9.14e-05	0.00428	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	8.2e-05	0.00384	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	8.2e-05	0.00384	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	8.16e-05	0.00382	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Biological oxidations—CYP27A1—osteoporosis	8.08e-05	0.00378	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	7.99e-05	0.00374	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	7.99e-05	0.00374	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metapathway biotransformation—CYP27A1—osteoporosis	7.97e-05	0.00373	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Biological oxidations—POMC—osteoporosis	7.93e-05	0.00371	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	7.68e-05	0.00359	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	7.58e-05	0.00355	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Corticotropin-releasing hormone—TGFB1—osteoporosis	7.55e-05	0.00353	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—PKM—osteoporosis	7.48e-05	0.0035	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—FDPS—osteoporosis	7.48e-05	0.0035	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	7.33e-05	0.00343	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Arachidonic acid metabolism—GPX1—osteoporosis	7.23e-05	0.00338	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—PGLS—osteoporosis	7.09e-05	0.00332	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—GPD2—osteoporosis	7.09e-05	0.00332	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—PNP—osteoporosis	6.49e-05	0.00304	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—ATIC—osteoporosis	6.49e-05	0.00304	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—ESR1—osteoporosis	6.48e-05	0.00303	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	6.39e-05	0.00299	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—osteoporosis	6.34e-05	0.00297	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Biological oxidations—CYP27A1—osteoporosis	6.29e-05	0.00295	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	6.22e-05	0.00291	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metapathway biotransformation—CYP27A1—osteoporosis	6.21e-05	0.0029	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—IRS1—osteoporosis	6.06e-05	0.00283	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	5.92e-05	0.00277	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	5.92e-05	0.00277	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	5.85e-05	0.00274	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—CA2—osteoporosis	5.52e-05	0.00258	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—OXCT1—osteoporosis	5.52e-05	0.00258	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	5.43e-05	0.00254	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	5.4e-05	0.00253	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—MGLL—osteoporosis	5.37e-05	0.00252	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Biological oxidations—POMC—osteoporosis	5.25e-05	0.00246	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	5.12e-05	0.0024	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	5.07e-05	0.00237	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—FDPS—osteoporosis	4.96e-05	0.00232	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—PKM—osteoporosis	4.96e-05	0.00232	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	4.86e-05	0.00227	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	4.8e-05	0.00225	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Phase 1 - Functionalization of compounds—POMC—osteoporosis	4.8e-05	0.00225	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	4.79e-05	0.00224	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—PGLS—osteoporosis	4.7e-05	0.0022	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—GPD2—osteoporosis	4.7e-05	0.0022	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	4.61e-05	0.00216	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—IDH2—osteoporosis	4.57e-05	0.00214	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—CYP27A1—osteoporosis	4.3e-05	0.00201	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—ATIC—osteoporosis	4.3e-05	0.00201	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—PNP—osteoporosis	4.3e-05	0.00201	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Biological oxidations—CYP19A1—osteoporosis	4.24e-05	0.00199	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	4.23e-05	0.00198	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	4.21e-05	0.00197	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metapathway biotransformation—CYP19A1—osteoporosis	4.18e-05	0.00196	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—ACP5—osteoporosis	4.18e-05	0.00196	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.13e-05	0.00193	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	3.99e-05	0.00187	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	3.98e-05	0.00186	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—TPI1—osteoporosis	3.89e-05	0.00182	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	3.88e-05	0.00182	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Phase 1 - Functionalization of compounds—POMC—osteoporosis	3.74e-05	0.00175	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—P4HB—osteoporosis	3.65e-05	0.00171	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—OXCT1—osteoporosis	3.65e-05	0.00171	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—CA2—osteoporosis	3.65e-05	0.00171	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—GAPDH—osteoporosis	3.59e-05	0.00168	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	3.56e-05	0.00167	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—MGLL—osteoporosis	3.56e-05	0.00167	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—RAP1A—osteoporosis	3.49e-05	0.00163	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—MYC—osteoporosis	3.37e-05	0.00158	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Biological oxidations—CYP19A1—osteoporosis	3.31e-05	0.00155	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	3.3e-05	0.00154	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	3.29e-05	0.00154	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metapathway biotransformation—CYP19A1—osteoporosis	3.26e-05	0.00153	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	3.1e-05	0.00145	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	3.1e-05	0.00145	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	3.07e-05	0.00144	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	3.07e-05	0.00144	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.05e-05	0.00143	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—IDH2—osteoporosis	3.03e-05	0.00142	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	3.02e-05	0.00141	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	2.89e-05	0.00135	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—CYP27A1—osteoporosis	2.85e-05	0.00133	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—ENO1—osteoporosis	2.82e-05	0.00132	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—PSMA5—osteoporosis	2.78e-05	0.0013	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—PSMA2—osteoporosis	2.78e-05	0.0013	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—ACP5—osteoporosis	2.77e-05	0.0013	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.73e-05	0.00128	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	2.64e-05	0.00123	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—TPI1—osteoporosis	2.57e-05	0.0012	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	2.55e-05	0.00119	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Biological oxidations—POMC—osteoporosis	2.55e-05	0.00119	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	2.52e-05	0.00118	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—P4HB—osteoporosis	2.42e-05	0.00113	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	2.42e-05	0.00113	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—FDPS—osteoporosis	2.4e-05	0.00113	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—PKM—osteoporosis	2.4e-05	0.00113	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—GAPDH—osteoporosis	2.38e-05	0.00111	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—RAP1A—osteoporosis	2.31e-05	0.00108	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—PGLS—osteoporosis	2.28e-05	0.00107	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—GPD2—osteoporosis	2.28e-05	0.00107	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—CYP19A1—osteoporosis	2.26e-05	0.00106	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—ATIC—osteoporosis	2.09e-05	0.000976	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—PNP—osteoporosis	2.09e-05	0.000976	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	2.05e-05	0.000962	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.02e-05	0.000944	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Biological oxidations—POMC—osteoporosis	1.99e-05	0.00093	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—FDPS—osteoporosis	1.87e-05	0.000877	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—PKM—osteoporosis	1.87e-05	0.000877	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—ENO1—osteoporosis	1.87e-05	0.000875	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—ADCY5—osteoporosis	1.84e-05	0.000863	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—PSMA2—osteoporosis	1.84e-05	0.000862	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—PSMA5—osteoporosis	1.84e-05	0.000862	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—GPX1—osteoporosis	1.84e-05	0.00086	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—GPD2—osteoporosis	1.78e-05	0.000831	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—PGLS—osteoporosis	1.78e-05	0.000831	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—OXCT1—osteoporosis	1.77e-05	0.00083	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—CA2—osteoporosis	1.77e-05	0.00083	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—MGLL—osteoporosis	1.73e-05	0.000809	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—MTHFR—osteoporosis	1.7e-05	0.000794	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.63e-05	0.000762	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—ATIC—osteoporosis	1.62e-05	0.00076	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—PNP—osteoporosis	1.62e-05	0.00076	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Biological oxidations—POMC—osteoporosis	1.53e-05	0.000718	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—IDH2—osteoporosis	1.47e-05	0.000687	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—PKM—osteoporosis	1.45e-05	0.000677	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—FDPS—osteoporosis	1.45e-05	0.000677	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—CA2—osteoporosis	1.38e-05	0.000646	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—OXCT1—osteoporosis	1.38e-05	0.000646	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—CYP27A1—osteoporosis	1.38e-05	0.000646	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—GPD2—osteoporosis	1.37e-05	0.000642	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—PGLS—osteoporosis	1.37e-05	0.000642	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—POMC—osteoporosis	1.36e-05	0.000635	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—MGLL—osteoporosis	1.35e-05	0.00063	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—ACP5—osteoporosis	1.34e-05	0.000629	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.33e-05	0.000621	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.27e-05	0.000594	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—PNP—osteoporosis	1.25e-05	0.000587	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—ATIC—osteoporosis	1.25e-05	0.000587	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—TPI1—osteoporosis	1.25e-05	0.000585	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—ADCY5—osteoporosis	1.22e-05	0.000572	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—GPX1—osteoporosis	1.22e-05	0.00057	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—P4HB—osteoporosis	1.17e-05	0.00055	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—GAPDH—osteoporosis	1.15e-05	0.000539	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—IDH2—osteoporosis	1.14e-05	0.000536	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—MTHFR—osteoporosis	1.12e-05	0.000526	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—RAP1A—osteoporosis	1.12e-05	0.000525	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—CYP27A1—osteoporosis	1.08e-05	0.000504	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—CA2—osteoporosis	1.07e-05	0.000499	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—OXCT1—osteoporosis	1.07e-05	0.000499	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—ACP5—osteoporosis	1.05e-05	0.00049	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—MGLL—osteoporosis	1.04e-05	0.000486	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.03e-05	0.000484	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	9.79e-06	0.000458	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—TPI1—osteoporosis	9.73e-06	0.000455	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—P4HB—osteoporosis	9.15e-06	0.000428	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—ENO1—osteoporosis	9.08e-06	0.000425	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—POMC—osteoporosis	8.99e-06	0.00042	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—GAPDH—osteoporosis	8.98e-06	0.00042	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—PSMA2—osteoporosis	8.94e-06	0.000419	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—PSMA5—osteoporosis	8.94e-06	0.000419	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—IDH2—osteoporosis	8.83e-06	0.000413	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—RAP1A—osteoporosis	8.75e-06	0.000409	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—CYP27A1—osteoporosis	8.31e-06	0.000389	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—ACP5—osteoporosis	8.08e-06	0.000378	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	7.63e-06	0.000357	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—TPI1—osteoporosis	7.51e-06	0.000352	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—CYP19A1—osteoporosis	7.26e-06	0.00034	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—ENO1—osteoporosis	7.07e-06	0.000331	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—P4HB—osteoporosis	7.06e-06	0.000331	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—PSMA5—osteoporosis	6.97e-06	0.000326	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—PSMA2—osteoporosis	6.97e-06	0.000326	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—GAPDH—osteoporosis	6.93e-06	0.000324	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—RAP1A—osteoporosis	6.75e-06	0.000316	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—ADCY5—osteoporosis	5.93e-06	0.000277	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—GPX1—osteoporosis	5.91e-06	0.000276	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—CYP19A1—osteoporosis	5.65e-06	0.000265	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—ENO1—osteoporosis	5.46e-06	0.000255	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—MTHFR—osteoporosis	5.45e-06	0.000255	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—PSMA5—osteoporosis	5.38e-06	0.000252	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—PSMA2—osteoporosis	5.38e-06	0.000252	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—ADCY5—osteoporosis	4.62e-06	0.000216	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—GPX1—osteoporosis	4.6e-06	0.000215	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—CYP19A1—osteoporosis	4.36e-06	0.000204	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—POMC—osteoporosis	4.36e-06	0.000204	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—MTHFR—osteoporosis	4.25e-06	0.000199	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—ADCY5—osteoporosis	3.56e-06	0.000167	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—GPX1—osteoporosis	3.55e-06	0.000166	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—POMC—osteoporosis	3.4e-06	0.000159	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—MTHFR—osteoporosis	3.28e-06	0.000153	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—POMC—osteoporosis	2.62e-06	0.000123	CbGpPWpGaD
